Treatment of Fanconi Anemia with Severe Bone Marrow Failure When HCT Carries Exceptional Mortality Risk (Age ≥35, Organ Dysfunction, or Malignancy)

In Fanconi anemia, when blood counts fall to severe levels and hematopoietic cell transplantation (HCT) is not feasible or is associated with exceptional risk of mortality, an alternative treatment strategy is required to maintain counts and quality of life.

Who this applies to: Patients with Fanconi anemia and severe bone marrow failure who have one or more of the following high-risk features: age 35 years or older, severe organ dysfunction, a pre-existing malignancy, or a life-threatening systemic infection — and for whom cure by HCT is not possible or preferred. In these patients, alternative therapies may maintain blood counts and quality of life.

Treatment approach (partial): Androgen therapy — using synthetic androgens — is an established option with more than 50 years of clinical use for cytopenias in Fanconi anemia. The complete regimen, sequencing, and monitoring strategy are detailed in the full protocol.

Treatment goal: response within three to four months, defined as stabilization of falling counts or an increase in hemoglobin or platelet counts.

Instant Access to Structured Evidence-Based Regimens

References

If blood counts decline to severe levels (Table 1) and cure by HCT is not possible or preferred, alternative therapies may maintain blood counts and quality of life in patients with FA.

Patients with an exceptional risk of HCT-related mortality (e.g., patients with severe organ dysfunction, those who are 35 years or older, and those with pre-existing malignancies or life-threatening systemic infections) may consider alternative treatment options first, such as the use of androgens.

Synthetic androgens, such as oxymetholone and danazol, have been used to treat cytopenias in patients with FA for more than 50 years.

Most patients who will respond do so within three to four months with stabilization of falling counts or an increase in the hemoglobin or platelet counts.

View source ↗